Submissions received by the 2019 Review of the Narcotic Drugs Act are published on the Office of Drug Control website.
This consultation closed on 2 April 2019.
The Department of Health sought comments from interested parties on the terms of reference for the Review of the Narcotic Drugs Act 1967 (the ND Act):
The primary focus of the Review is on the regulatory framework for the cultivation, production and manufacture of medicinal cannabis under the ND Act. Interest parties can find further information, including in relation to key themes, specific issues and examples of matters that do not fall within the scope of the review in the Discussion paper.
Discussion paper released for consultation on Monday, 4 March 2019.
Submissions close at 5:00pm on Tuesday, 2 April 2019.
The Review is required to invite public submissions, to conduct targeted consultations with interested stakeholders and through public forums, and to consult the Australian Advisory Council on the Medicinal Use of Cannabis. Three public consultation forums have been held:
The public forums enabled interested parties to raise issues that could be considered in the review.
The Discussion Paper and invitation for written submissions continues the public consultation.
Submissions may address any, or all, of the terms of reference identified above or the key themes and/or specific issues identified in the Discussion Paper.
The Review is particularly interested in hearing about your practical engagement with the medicinal cannabis scheme in the ND Act. We welcome examples and case studies of issues you have encountered. Concrete proposals for legislative and administrative reform are also invited.
If you are unsure whether a topic or issue fits within the Terms of Reference, the Review invites you to email the Review Secretariat at ReviewNarcoticDrugsAct@health.gov.au, or call us on 1800 020 653, seeking clarification. The Secretariat will endeavour to respond as soon as possible.
Any questions relating to submissions should be directed to the Review Secretariat by email to ReviewNarcoticDrugsAct@health.gov.au or by telephone to 1800 020 653.
All submissions will be placed on this website unless marked confidential or indicated otherwise in the submission form (see Privacy information).
The final report in the Review is to be tabled in both Houses of Parliament by 29 October 2019.
All submissions will be placed on this website unless marked confidential or indicated otherwise in the submission form. Please note that the Review collects your personal information in this submission in order to:
Please do not include personal information about other individuals in the body of your submission. The Review notes that personal information in this context means information or an opinion about an individual whose identity is apparent, or can reasonably be ascertained, from the information or opinion.
More information on privacy can be found on our website.
On 4 March 2029, Professor John McMillan AO, who has been appointed to conduct an independent review of the Narcotic Drugs Act 1967, published a Discussion Paper inviting written submissions from interested parties by 2 April 2019. This date ensured that consultation period ended and all submissions were received prior to the 2019 Federal election being called.
Professor McMillan thanks those individuals and organisations for their valuable feedback.
In total, 25 submissions and other comments were received in response to the invitation to comment.
All submissions that were not marked as confidential are now available in PDF format.
